Third Rock Ventures

Third Rock Ventures is a venture capital firm with offices in Boston and San Francisco.[1] Founded in 2007, the firm invests in biotechnology startups.[2]

Third Rock Ventures
IndustryVenture capital
Founded2007
HeadquartersBoston, Massachusetts, United States
Key people
Mark J. Levin
Kevin P. Starr
Robert I. Tepper
Websitethirdrockventures.com

Funding and investments

Third Rock Ventures has raised $3.8 billion since it was created and invested in more than 60 companies, including Sage Therapeutics, Editas Medicine, Constellation Pharmaceuticals and Flare Therapeutics.[3][4]

References
  1. DeAngelis, Allison. "Third Rock Ventures plots next chapter after raising $1.1 billion fund". STAT. Retrieved 16 April 2024.
  2. Timmeran, Luke (31 October 2016). "Third Rock Ventures, One of Biotech's Daring Investors, Raises $616M For More Startups". Forbes. Retrieved 22 August 2018.
  3. Terry, Mark. "In Tough Biotech Market, Third Rock Raises New $1.1B Fund". BioSpace. Retrieved 16 April 2024.
  4. DeAngelis, Allison. "Third Rock Ventures plots next chapter after raising $1.1 billion fund". STAT. Retrieved 16 April 2024.

Notes


    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.